| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.009 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |